Calcium Chloride; Dextrose; Magnesium Chloride; Sodium Chloride; Sodium Lactate Intraperitoneal Injection, Solution shortage
To Be Discontinued 18 presentations · 1 manufacturers · first FDA posting 2026-08-03 · last update 2026-08-03
Manufacturers: Vantive US Healthcare LLC
Stated reasons (per FDA): Not stated
Presentations
| Presentation | Manufacturer | Status | Reason | Notes (FDA) | Dates |
|---|---|---|---|---|---|
| DIANEAL Low Calcium with Dextrose, Intraperitoneal Injection, Solution, 18.3 mg/100 mL; 1.5 g/100 mL; 5.08 mg/100 mL; 538 mg/100 mL; 448 mg/100 mL (NDC 0941-0409-07) | Vantive US Healthcare LLC | To Be Discontinued | — | A business decision was made to discontinue manufacture of the drug. | Posted 08/03/2026 Updated 08/03/2026 Discontinued 08/03/2026 |
| DIANEAL PD-2 with Dextrose, Intraperitoneal Injection, Solution, 25.7 mg/100 mL; 1.5 g/100 mL; 5.08 mg/100 mL; 538 mg/100 mL; 448 mg/100 mL (NDC 0941-0411-06) | Vantive US Healthcare LLC | To Be Discontinued | — | A business decision was made to discontinue manufacture of the drug. | Posted 08/03/2026 Updated 08/03/2026 Discontinued 08/03/2026 |
| DIANEAL PD-2 with Dextrose, Intraperitoneal Injection, Solution, 25.7 mg/100 mL; 1.5 g/100 mL; 5.08 mg/100 mL; 538 mg/100 mL; 448 mg/100 mL (NDC 0941-0411-07) | Vantive US Healthcare LLC | To Be Discontinued | — | A business decision was made to discontinue manufacture of the drug. | Posted 08/03/2026 Updated 08/03/2026 Discontinued 08/03/2026 |
| DIANEAL PD-2 with Dextrose, Intraperitoneal Injection, Solution, 25.7 mg/100 mL; 2.5 g/100 mL; 5.08 mg/100 mL; 538 mg/100 mL; 448 mg/100 mL (NDC 0941-0413-06) | Vantive US Healthcare LLC | To Be Discontinued | — | A business decision was made to discontinue manufacture of the drug. | Posted 08/03/2026 Updated 08/03/2026 Discontinued 08/03/2026 |
| DIANEAL PD-2 with Dextrose, Intraperitoneal Injection, Solution, 25.7 mg/100 mL; 2.5 g/100 mL; 5.08 mg/100 mL; 538 mg/100 mL; 448 mg/100 mL (NDC 0941-0413-07) | Vantive US Healthcare LLC | To Be Discontinued | — | A business decision was made to discontinue manufacture of the drug. | Posted 08/03/2026 Updated 08/03/2026 Discontinued 08/03/2026 |
| DIANEAL PD-2 with Dextrose, Intraperitoneal Injection, Solution, 25.7 mg/100 mL; 4.25 g/100 mL; 5.08 mg/100 mL; 538 mg/100 mL; 448 mg/100 mL (NDC 0941-0415-06) | Vantive US Healthcare LLC | To Be Discontinued | — | A business decision was made to discontinue manufacture of the drug. | Posted 08/03/2026 Updated 08/03/2026 Discontinued 08/03/2026 |
| DIANEAL PD-2 with Dextrose, Intraperitoneal Injection, Solution, 25.7 mg/100 mL; 4.25 g/100 mL; 5.08 mg/100 mL; 538 mg/100 mL; 448 mg/100 mL (NDC 0941-0415-07) | Vantive US Healthcare LLC | To Be Discontinued | — | A business decision was made to discontinue manufacture of the drug. | Posted 08/03/2026 Updated 08/03/2026 Discontinued 08/03/2026 |
| DIANEAL Low Calcium with Dextrose, Intraperitoneal Injection, Solution, 18.3 mg/100 mL; 1.5 g/100 mL; 5.08 mg/100 mL; 538 mg/100 mL; 448 mg/100 mL (NDC 0941-0424-51) | Vantive US Healthcare LLC | To Be Discontinued | — | A business decision was made to discontinue manufacture of the drug. | Posted 08/03/2026 Updated 08/03/2026 Discontinued 08/03/2026 |
| DIANEAL PD-2 with Dextrose, Intraperitoneal Injection, Solution, 25.7 mg/100 mL; 1.5 g/100 mL; 5.08 mg/100 mL; 538 mg/100 mL; 448 mg/100 mL (NDC 0941-0426-52) | Vantive US Healthcare LLC | To Be Discontinued | — | A business decision was made to discontinue manufacture of the drug. | Posted 08/03/2026 Updated 08/03/2026 Discontinued 08/03/2026 |
| DIANEAL PD-2 with Dextrose, Intraperitoneal Injection, Solution, 25.7 mg/100 mL; 1.5 g/100 mL; 5.08 mg/100 mL; 538 mg/100 mL; 448 mg/100 mL (NDC 0941-0426-53) | Vantive US Healthcare LLC | To Be Discontinued | — | A business decision was made to discontinue manufacture of the drug. | Posted 08/03/2026 Updated 08/03/2026 Discontinued 08/03/2026 |
| DIANEAL PD-2 with Dextrose, Intraperitoneal Injection, Solution, 25.7 mg/100 mL; 2.5 g/100 mL; 5.08 mg/100 mL; 538 mg/100 mL; 448 mg/100 mL (NDC 0941-0427-52) | Vantive US Healthcare LLC | To Be Discontinued | — | A business decision was made to discontinue manufacture of the drug. | Posted 08/03/2026 Updated 08/03/2026 Discontinued 08/03/2026 |
| DIANEAL PD-2 with Dextrose, Intraperitoneal Injection, Solution, 25.7 mg/100 mL; 2.5 g/100 mL; 5.08 mg/100 mL; 538 mg/100 mL; 448 mg/100 mL (NDC 0941-0427-53) | Vantive US Healthcare LLC | To Be Discontinued | — | A business decision was made to discontinue manufacture of the drug. | Posted 08/03/2026 Updated 08/03/2026 Discontinued 08/03/2026 |
| DIANEAL PD-2 with Dextrose, Intraperitoneal Injection, Solution, 25.7 mg/100 mL; 4.25 g/100 mL; 5.08 mg/100 mL; 538 mg/100 mL; 448 mg/100 mL (NDC 0941-0429-52) | Vantive US Healthcare LLC | To Be Discontinued | — | A business decision was made to discontinue manufacture of the drug. | Posted 08/03/2026 Updated 08/03/2026 Discontinued 08/03/2026 |
| DIANEAL PD-2 with Dextrose, Intraperitoneal Injection, Solution, 25.7 mg/100 mL; 4.25 g/100 mL; 5.08 mg/100 mL; 538 mg/100 mL; 448 mg/100 mL (NDC 0941-0429-53) | Vantive US Healthcare LLC | To Be Discontinued | — | A business decision was made to discontinue manufacture of the drug. | Posted 08/03/2026 Updated 08/03/2026 Discontinued 08/03/2026 |
| DIANEAL Low Calcium with Dextrose, Intraperitoneal Injection, Solution, 18.3 mg/100 mL; 2.5 g/100 mL; 5.08 mg/100 mL; 538 mg/100 mL; 448 mg/100 mL (NDC 0941-0430-51) | Vantive US Healthcare LLC | To Be Discontinued | — | A business decision was made to discontinue manufacture of the drug. | Posted 08/03/2026 Updated 08/03/2026 Discontinued 08/03/2026 |
| DIANEAL Low Calcium with Dextrose, Intraperitoneal Injection, Solution, 18.3 mg/100 mL; 4.25 g/100 mL; 5.08 mg/100 mL; 538 mg/100 mL; 448 mg/100 mL (NDC 0941-0433-51) | Vantive US Healthcare LLC | To Be Discontinued | — | A business decision was made to discontinue manufacture of the drug. | Posted 08/03/2026 Updated 08/03/2026 Discontinued 08/03/2026 |
| DIANEAL Low Calcium with Dextrose, Intraperitoneal Injection, Solution, 18.3 mg/100 mL; 2.5 g/100 mL; 5.08 mg/100 mL; 538 mg/100 mL; 448 mg/100 mL (NDC 0941-0457-05) | Vantive US Healthcare LLC | To Be Discontinued | — | A business decision was made to discontinue manufacture of the drug. | Posted 08/03/2026 Updated 08/03/2026 Discontinued 08/03/2026 |
| DIANEAL Low Calcium with Dextrose, Intraperitoneal Injection, Solution, 18.3 mg/100 mL; 4.25 g/100 mL; 5.08 mg/100 mL; 538 mg/100 mL; 448 mg/100 mL (NDC 0941-0459-05) | Vantive US Healthcare LLC | To Be Discontinued | — | A business decision was made to discontinue manufacture of the drug. | Posted 08/03/2026 Updated 08/03/2026 Discontinued 08/03/2026 |
Get the weekly shortage roundup: a free email of FDA shortage changes (open form)